Cargando…

Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’

BACKGROUND: Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculos...

Descripción completa

Detalles Bibliográficos
Autores principales: Salahuddin, Nawal, Ali, Farheen, Hasan, Zahra, Rao, Nisar, Aqeel, Masooma, Mahmood, Faisal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556334/
https://www.ncbi.nlm.nih.gov/pubmed/23331510
http://dx.doi.org/10.1186/1471-2334-13-22
_version_ 1782257173787574272
author Salahuddin, Nawal
Ali, Farheen
Hasan, Zahra
Rao, Nisar
Aqeel, Masooma
Mahmood, Faisal
author_facet Salahuddin, Nawal
Ali, Farheen
Hasan, Zahra
Rao, Nisar
Aqeel, Masooma
Mahmood, Faisal
author_sort Salahuddin, Nawal
collection PubMed
description BACKGROUND: Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculosis (TB) could influence recovery. METHODS: Two hundred and fifty nine patients with pulmonary TB were randomized to receive either 600,000 IU of Intramuscular vitamin D(3) or placebo for 2 doses. Assessments were performed at 4, 8 and 12 weeks. Early secreted and T cell activated 6 kDa (ESAT6) and Mycobacterium tuberculosis sonicate (MTBs) antigen induced whole blood stimulated IFN-g responses were measured at 0 and 12 weeks. Statistical comparisons between outcome variables at 0 and 12 weeks were performed using Student’s t-test and Chi(2) tests. RESULTS: After 12 weeks, the vitamin D supplemented arm demonstrated significantly greater mean weight gain (kg) + 3.75, (3.16 – 4.34) versus + 2.61 (95% CI 1.99 – 3.23) p 0.009 and lesser residual disease by chest radiograph; number of zones involved 1.35 v/s 1.82 p 0.004 (95% CI 0.15, 0.79) and 50% or greater reduction in cavity size 106 (89.8%) v/s 111 (94.8%), p 0.035. Vitamin D supplementation led to significant increase in MTBs-induced IFN-g secretion in patients with baseline ‘Deficient’ 25-hydroxyvitamin D serum levels (p 0.021). CONCLUSIONS: Supplementation with high doses of vitamin D accelerated clinical, radiographic improvement in all TB patients and increased host immune activation in patients with baseline ‘Deficient’ serum vitamin D levels. These results suggest a therapeutic role for vitamin D in the treatment of TB. TRIAL REGISTRATION: ClinicalTrials.gov; No. NCT01130311; URL: clinicaltrials.gov
format Online
Article
Text
id pubmed-3556334
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35563342013-01-30 Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’ Salahuddin, Nawal Ali, Farheen Hasan, Zahra Rao, Nisar Aqeel, Masooma Mahmood, Faisal BMC Infect Dis Research Article BACKGROUND: Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculosis (TB) could influence recovery. METHODS: Two hundred and fifty nine patients with pulmonary TB were randomized to receive either 600,000 IU of Intramuscular vitamin D(3) or placebo for 2 doses. Assessments were performed at 4, 8 and 12 weeks. Early secreted and T cell activated 6 kDa (ESAT6) and Mycobacterium tuberculosis sonicate (MTBs) antigen induced whole blood stimulated IFN-g responses were measured at 0 and 12 weeks. Statistical comparisons between outcome variables at 0 and 12 weeks were performed using Student’s t-test and Chi(2) tests. RESULTS: After 12 weeks, the vitamin D supplemented arm demonstrated significantly greater mean weight gain (kg) + 3.75, (3.16 – 4.34) versus + 2.61 (95% CI 1.99 – 3.23) p 0.009 and lesser residual disease by chest radiograph; number of zones involved 1.35 v/s 1.82 p 0.004 (95% CI 0.15, 0.79) and 50% or greater reduction in cavity size 106 (89.8%) v/s 111 (94.8%), p 0.035. Vitamin D supplementation led to significant increase in MTBs-induced IFN-g secretion in patients with baseline ‘Deficient’ 25-hydroxyvitamin D serum levels (p 0.021). CONCLUSIONS: Supplementation with high doses of vitamin D accelerated clinical, radiographic improvement in all TB patients and increased host immune activation in patients with baseline ‘Deficient’ serum vitamin D levels. These results suggest a therapeutic role for vitamin D in the treatment of TB. TRIAL REGISTRATION: ClinicalTrials.gov; No. NCT01130311; URL: clinicaltrials.gov BioMed Central 2013-01-19 /pmc/articles/PMC3556334/ /pubmed/23331510 http://dx.doi.org/10.1186/1471-2334-13-22 Text en Copyright ©2013 Salahuddin et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Salahuddin, Nawal
Ali, Farheen
Hasan, Zahra
Rao, Nisar
Aqeel, Masooma
Mahmood, Faisal
Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’
title Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’
title_full Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’
title_fullStr Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’
title_full_unstemmed Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’
title_short Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’
title_sort vitamin d accelerates clinical recovery from tuberculosis: results of the succinct study [supplementary cholecalciferol in recovery from tuberculosis]. a randomized, placebo-controlled, clinical trial of vitamin d supplementation in patients with pulmonary tuberculosis’
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556334/
https://www.ncbi.nlm.nih.gov/pubmed/23331510
http://dx.doi.org/10.1186/1471-2334-13-22
work_keys_str_mv AT salahuddinnawal vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis
AT alifarheen vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis
AT hasanzahra vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis
AT raonisar vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis
AT aqeelmasooma vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis
AT mahmoodfaisal vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis